NASDAQ: SAVA - Cassava Sciences, Inc.

Yield per half year: -85.66%
Dividend yield: 0.00%
Sector: Healthcare

Company Analysis Cassava Sciences, Inc.

Download the report: word Word pdf PDF

1. Summary

Advantages

  • Price (2.83 $) is less than fair price (21.17 $)
  • Current debt level 0.0917% is below 100% and has decreased over 5 years from 0.383%.

Disadvantages

  • Dividends (0%) are below the sector average (0.541%).
  • The stock's return over the last year (-89.6%) is lower than the sector average (-12.5%).
  • The company's current efficiency (ROE=-70.72%) is lower than the sector average (ROE=9.61%)

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

2. Share price and performance

2.1. Share price

2.2. News

2.3. Market efficiency

Cassava Sciences, Inc. Healthcare Index
7 days -8.4% 2.5% -0.7%
90 days -90.5% -17.8% 2.6%
1 year -89.6% -12.5% 25.7%

SAVA vs Sector: Cassava Sciences, Inc. has significantly underperformed the "Healthcare" sector by -77.1% over the past year.

SAVA vs Market: Cassava Sciences, Inc. has significantly underperformed the market by -115.26% over the past year.

Slightly volatile price: SAVA is more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical deviations of about +/- 5-15% per week.

Long period: SAVA with weekly volatility of -1.72% over the past year.

3. Summary of the report

3.1. General

P/E: 0
P/S: -707555.2

3.2. Revenue

EPS -2.32
ROE -70.72%
ROA -64.1%
ROIC -17.91%
Ebitda margin 0%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Below fair price: The current price (2.83 $) is lower than the fair price (21.17 $).

Price significantly below the fair price: The current price (2.83 $) is 648.1% lower than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (48.77).

P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (49.04).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (7.3) is higher than that of the sector as a whole (4.83).

P/BV vs Market: The company's P/BV (7.3) is higher than that of the market as a whole (3.17).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (-707555.2) is lower than that of the sector as a whole (33.77).

P/S vs Market: The company's P/S indicator (-707555.2) is lower than that of the market as a whole (10.24).

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (-8.45) is higher than that of the sector as a whole (-22.17).

EV/Ebitda vs Market: The company's EV/Ebitda (-8.45) is lower than that of the market as a whole (28.32).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Rising and has grown by 333.52% over the last 5 years.

Earnings Slowdown: The last year's return (0%) is below the 5-year average return (333.52%).

Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (4135.44%).

5.4. ROE

ROE vs Sector: The company's ROE (-70.72%) is lower than that of the sector as a whole (9.61%).

ROE vs Market: The company's ROE (-70.72%) is lower than that of the market as a whole (10.71%).

5.5. ROA

ROA vs Sector: The company's ROA (-64.1%) is lower than that of the sector as a whole (0.3443%).

ROA vs Market: The company's ROA (-64.1%) is lower than that of the market as a whole (6.47%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (-17.91%) is lower than that of the sector as a whole (7.63%).

ROIC vs Market: The company's ROIC (-17.91%) is lower than that of the market as a whole (10.79%).

6. Finance

6.1. Assets and debt

Debt level: (0.0917%) is quite low in relation to assets.

Debt reduction: over 5 years, the debt has decreased from 0.383% to 0.0917%.

Excess of debt: The debt is not covered by net income, percentage -0.143%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0% is below the average for the sector '0.541%.

7.2. Stability and increase in payments

Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.5.

Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

Transaction date Insider Type Price Volume Quantity
29.03.2022 GUSSIN ROBERT Z
Director
Purchase 21.53 160 829 7 470

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Cassava Sciences, Inc.

9.3. Comments